March 22, 2026 01:12 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Mamata unveils TMC candidate list for Bengal polls; to face Suvendu in Bhabanipur | ‘Not a one-day battle for me’: Mamata Banerjee on facing Suvendu Adhikari in Bhabanipur | Mamata vs Suvendu: Bhabanipur set for high-voltage showdown | Barbaric: India condemns Pakistani airstrike on Kabul hospital | Middle East conflict: Israel says it killed key Iranian commander during overnight strike | Middle East on edge: Kataeb Hezbollah commander Abu Ali al-Askari killed | Middle East on edge: Kataeb Hezbollah commander Abu Ali al-Askari killed | Afghanistan claims Pakistani airstrike on Kabul hospital left 400 killed, Islamabad denies | ECI orders major reshuffle in Bengal police brass a day after poll announcement | 10 patients killed in fire at SCB Medical College Hospital in Cuttack; staff injured
Omicron
Pixabay

Russian nasal vaccine effective against Omicron variant: Researchers

| @indiablooms | Mar 20, 2022, at 08:31 pm

Moscow/UNI/Sputnik: The new Russian nasal vaccine against the coronavirus infection has demonstrated effectiveness against the Omicron variant, Alexander Gintsburg, the director of Russia's Gamaleya Research Center for Epidemiology and Microbiology, told Sputnik.

"Yes, it is being tested against Omicron, it works," Gintsburg said. According to the chief researcher, the new vaccine will be used as a booster, in addition to the Sputnik V shots, for now, until there is enough evidence that this new intranasal vaccine gives the same level of protection as injection.

The Russian health ministry authorized clinical trials of the new intranasal vaccine in October 2021.

In November, Russian President Vladimir Putin offered to become a volunteer in the testing of the new vaccine and said that he felt no side effects after getting the procedure.

Gintsburg told Sputnik earlier this month that the new intranasal vaccine had already been administered to over 100 people, as part of the trials, who showed no negative side effects.

On Friday, the Gamaleya center applied for the registration of the new nasal vaccine against Covid-19. According to Gintsburg, it is expected to be registered earlier than planned.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.